TABLE 1

Baseline characteristics of the two study groups

Group 1
Group 2
P
NMeanSDNMeanSD
Male sex (%)1,01452.751762.9<0.0001
Age diagnosed (years)1,01457.110.751758.39.660.02
Age treated with metformin (years)1,01459.111.251763.110.5<0.0001
BMI (kg/m2)99032.55.750929.54.9<0.0001
Baseline A1C (%)1,0148.61.65179.21.4<0.0001
Average dose (g)1,0141.240.45171.280.40.08
Adherence (%)1,01475.918.051777.916.70.06
Creatinine clearance (ml/min)98397.734.049383.930.0<0.0001